rs876657898
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_016239.4(MYO15A):βc.349_357delβ(p.Tyr117_Arg119del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.000855 in 1,611,294 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (β β ).
Frequency
Genomes: π 0.00060 ( 0 hom., cov: 33)
Exomes π: 0.00088 ( 1 hom. )
Consequence
MYO15A
NM_016239.4 inframe_deletion
NM_016239.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.03
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_016239.4.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYO15A | NM_016239.4 | c.349_357del | p.Tyr117_Arg119del | inframe_deletion | 2/66 | ENST00000647165.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYO15A | ENST00000647165.2 | c.349_357del | p.Tyr117_Arg119del | inframe_deletion | 2/66 | NM_016239.4 | P1 | ||
MYO15A | ENST00000583079.1 | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.000598 AC: 91AN: 152196Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
91
AN:
152196
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000495 AC: 117AN: 236402Hom.: 0 AF XY: 0.000512 AC XY: 67AN XY: 130974
GnomAD3 exomes
AF:
AC:
117
AN:
236402
Hom.:
AF XY:
AC XY:
67
AN XY:
130974
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000881 AC: 1286AN: 1458980Hom.: 1 AF XY: 0.000880 AC XY: 639AN XY: 725792
GnomAD4 exome
AF:
AC:
1286
AN:
1458980
Hom.:
AF XY:
AC XY:
639
AN XY:
725792
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000597 AC: 91AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.000591 AC XY: 44AN XY: 74472
GnomAD4 genome
AF:
AC:
91
AN:
152314
Hom.:
Cov.:
33
AF XY:
AC XY:
44
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:5
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 19, 2024 | In-frame deletion of 3 amino acids in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 25, 2019 | The p.Tyr117_Arg119del variant in MYO15A has been previously reported by our laboratory in 1 individual with hearing loss, and has also been identified in 0.08% (103/120036) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant is a deletion of three amino acids at positions 117 to 119 and is not predicted to alter the protein reading-frame of the gene. It is unclear if this deletion will impact the protein function. In summary, the clinical significance of the p.Tyr117_Arg119del variant is uncertain. ACMG/AMP Criteria applied: BS1_Supporting. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Oct 16, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 12, 2022 | This variant, c.349_357del, results in the deletion of 3 amino acid(s) of the MYO15A protein (p.Tyr117_Arg119del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs752352091, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with MYO15A-related conditions. ClinVar contains an entry for this variant (Variation ID: 228948). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2017 | - - |
Autosomal recessive nonsyndromic hearing loss 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 03, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at